Health

Scientist recommends ways to improve electronic health records

In an editorial in the Journal of General Internal Medicine, Regenstrief Institute research scientist Michael Weiner, MD, MPH highlights shortcomings of electronic health records (EHRs) in living up to their full potential, ...

Diseases, Conditions, Syndromes

ACIP recommends catch-up HPV vaccines through age 26

(HealthDay)—Catch-up human papillomavirus (HPV) vaccinations are recommended for all persons through age 26 years and should be considered for some persons aged 27 to 45 years, according to research published in the Aug. ...

Addiction

Research uses big data to track and treat drug abuse

The underground culture of hardcore drug abuse is dynamic and evolves rapidly. Street names for drugs, hot spots where users go for their fix, and new, dangerous strains laced with different substances change frequently and ...

Health

Take a bath 90 minutes before bedtime to get better sleep

Biomedical engineers at The University of Texas at Austin may have found a way for people to get better shuteye. Systematic review protocols—a method used to search for and analyze relevant data—allowed researchers to ...

Diseases, Conditions, Syndromes

Measles vaccination: 'All for one and one for all'

Measles was declared eradicated in the United States in 2000, but has reappeared in recent months in the form of outbreaks in several states. Of the 704 people in the U.S. infected with this highly contagious virus in 2019, ...

Medical research

A cell atlas of the aging lung

Aging promotes lung function decline and increases susceptibility to diseases of the respiratory tract. In order to understand these effects in detail, researchers at Helmholtz Zentrum München, a partner in the German Center ...

Medical research

Searching for side effects

Extracting relevant information from the scientific literature about side effects and adverse drug reactions to pharmaceutical products is an important part of data mining in this area. Writing in the International Journal ...

Medications

Empagliflozin in type 2 diabetes: Added benefit not proven

Empagliflozin (trade name Jardiance) has been approved since May 2014 for adults with type 2 diabetes mellitus in whom diet and exercise alone do not provide adequate glycaemic control. The German Institute for Quality and ...

page 1 from 2